APOH and autoimmune polyendocrinopathy: Vancomycin treatment in APS-prone (NZW × BXSB) F1 mice reduces anti-β2GPI antibody production, accompanied by lower Th17 and T follicular helper cell frequencies in secondary lymphoid tissues and reduced autoantibody levels (64).